David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
J Med Screen. 2021 Dec;28(4):379-388. doi: 10.1177/0969141321997482. Epub 2021 Mar 8.
Digital health care offers an opportunity to scale and personalize cancer screening programs, such as mailed outreach for colorectal cancer (CRC) screening. However, studies that describe the patient selection strategy and process for CRC screening are limited. Our objective was to evaluate implementation strategies for selecting patients for CRC screening programs in large health care systems.
We conducted a systematic review of 30 studies along with key informant surveys and interviews to describe programmatic implementation strategies for selecting patients for CRC screening. PubMed and Embase were searched since inception through December 2018, and hand searches were performed of the retrieved reference lists but none were incorporated ( = 0). No language exclusions were applied.
Common criteria for outreach exclusion included: being up-to-date with routine CRC screening ( = 22), comorbidities ( = 20), and personal history ( = 22) or family history of cancer ( = 9). Key informant surveys and interviews were performed ( = 28) to understand data sources and practices for patient outreach selection, and found that 13 studies leveraged electronic medical care records, 10 studies leveraged a population registry (national, municipal, community, health), 4 studies required patient opt-in, and 1 study required primary care provider referral. Broad ranges in fecal immunochemical test completion were observed in community clinic ( = 8, 31.0-59.6%), integrated health system ( = 5, 21.2-82.7%), and national regional CRC screening programs ( = 17, 23.0-64.7%). Six studies used technical codes, and four studies required patient self-reporting from a questionnaire to participate.
This systematic review provides health systems with the diverse outreach practices and technical tools to support efforts to automate patient selection for CRC screening outreach.
数字医疗为扩大和个性化癌症筛查计划(如邮寄结直肠癌(CRC)筛查外展服务)提供了机会。然而,描述 CRC 筛查患者选择策略和流程的研究有限。我们的目标是评估大型医疗保健系统中选择 CRC 筛查计划患者的实施策略。
我们对 30 项研究进行了系统评价,并进行了关键信息提供者调查和访谈,以描述 CRC 筛查患者选择的计划实施策略。从创建到 2018 年 12 月,我们在 PubMed 和 Embase 上进行了搜索,并且对检索到的参考文献进行了手工搜索,但没有纳入任何研究( = 0)。未应用语言排除。
外展排除的常见标准包括:定期接受 CRC 筛查( = 22)、合并症( = 20)、个人史( = 22)或癌症家族史( = 9)。进行了关键信息提供者调查和访谈( = 28)以了解患者外展选择的数据来源和实践,发现 13 项研究利用了电子医疗记录,10 项研究利用了人群登记册(国家、市、社区、卫生),4 项研究要求患者选择,1 项研究要求初级保健提供者转诊。在社区诊所( = 8,31.0-59.6%)、综合卫生系统( = 5,21.2-82.7%)和国家区域 CRC 筛查计划( = 17,23.0-64.7%)中观察到粪便免疫化学检测完成率的广泛差异。六项研究使用了技术代码,四项研究要求患者从问卷中自我报告以参与。
本系统评价为医疗系统提供了多样化的外展实践和技术工具,以支持自动化 CRC 筛查外展患者选择的努力。